文献速递细菌感染、耐药与抗菌药物医院感染防控新发突发、热带与寄生虫病

境外住院患者作为多重耐药菌输入者的横断面研究

Patients hospitalized abroad as importers of multiresistant bacteria-a cross-sectional study.
PubMed 文献 · Clin Microbiol Infect · 2017-02-11

该横断面研究分析了2010至2013年间在赫尔辛基大学医院就诊的1122例境外住院后患者,筛查多重耐药菌定植情况。结果显示,在(亚)热带地区住院者的定植率(55%)高于温带地区(17%),且11%的定植者后续发生多重耐药菌感染。研究识别了目的地、转院、短时间间隔、年轻年龄、手术、境外居住、探亲访友和抗菌药物使用等独立危险因素。

要点

  • 境外住院后患者多重耐药菌定植率在(亚)热带地区为55%,温带地区为17%。
  • ESBL-PE定植率在(亚)热带地区为50%,温带地区为12%。
  • 11%的多重耐药菌定植者发生多重耐药菌感染。

核心结论

  • 境外住院后患者多重耐药菌定植率在(亚)热带地区高于其他地区,且11%的定植者发生多重耐药菌感染。
  • 研究识别了多个独立危险因素,为低流行国家的感染控制指南提供了依据。

研究设计与样本

  • 横断面研究,收集2010至2013年间在赫尔辛基大学医院治疗的1122例境外住院后患者的数据。
  • 对患者筛查MRSA、ESBL-PE、VRE、CPE、多重耐药铜绿假单胞菌和多重耐药鲍曼不动杆菌。
  • 通过多因素分析探索定植的危险因素。

主要发现

  • (亚)热带地区住院者的多重耐药菌定植率为55%(208/377),温带地区为17%(125/745)。
  • ESBL-PE定植率在(亚)热带地区为50%(190/377),温带地区为12%(92/745)。
  • CPE定植率在(亚)热带地区为3.2%(12/377),温带地区为0.4%(3/745)。
  • MRSA定植率在(亚)热带地区为6.6%(25/377),温带地区为2.4%(18/745)。
  • 定植率最高为南亚返回者(77.6%;38/49),其次为拉丁美洲(60%;9/16)、非洲(60%;15/25)和东亚及东南亚(52.5%;94/179)。

关键数值与推荐

  • 目的地、(亚)热带地区住院、转院、短时间间隔、年轻年龄、手术干预、境外居住、探亲访友和抗菌药物使用为定植的独立危险因素。
  • 11%(38/333)的定植者发生多重耐药菌感染。

临床怎么用

  • 对境外住院后患者,尤其从(亚)热带地区返回者,应进行多重耐药菌筛查。
  • 识别独立危险因素有助于制定低流行国家的感染控制指南。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The pandemic spread of multidrug-resistant (MDR) bacteria poses a threat to healthcare worldwide, with highest prevalence in indigent regions of the (sub)tropics. As hospitalization constitutes a major risk factor for colonization, infection control management in low-prevalence countries urgently needs background data on patients hospitalized abroad. METHODS: We collected data on 1122 patients who, after hospitalization abroad, were treated at the Helsinki University Hospital between 2010 and 2013. They were screened for methicillin-resistant Staphylococcus aureus (MRSA), extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE), vancomycin-resistant enterococci, carbapenemase-producing Enterobacteriaceae (CPE), multiresistant Pseudomonas aeruginosa and multiresistant Acinetobacter baumannii. Risk factors for colonization were explored by multivariate analysis. RESULTS: MDR colonization rates were higher for those hospitalized in the (sub)tropics (55%; 208/377) compared with temperate zones (17%; 125/745). For ESBL-PE the percentages were 50% (190/377) versus 12% (92/745), CPE 3.2% (12/377) versus 0.4% (3/745) and MRSA 6.6% (25/377) versus 2.4% (18/745). Colonization rates proved highest in those returning from South Asia (77.6%; 38/49), followed by those having visited Latin America (60%; 9/16), Africa (60%; 15/25) and East and Southeast Asia (52.5%; 94/179). Destination, interhospital transfer, short time interval to hospitalization, young age, surgical intervention, residence abroad, visiting friends and relatives, and antimicrobial use proved independent risk factors for colonization. CONCLUSIONS: Post-hospitalization colonization rates proved higher in the (sub)tropics than elsewhere; 11% (38/333) of carriers developed an MDR infection. We identified several independent risk factors for contracting MDR bacteria. The data provide a basis for infection control guidelines in low-prevalence countries.

来源:Clin Microbiol Infect,查看原文。版权归原作者所有。

引用

  1. Khawaja T, Kirveskari J, Johansson S, et al. Patients hospitalized abroad as importers of multiresistant bacteria-a cross-sectional study. Clin Microbiol Infect. 2017. PMID: 28196696. doi:10.1016/j.cmi.2017.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。